News

NEW CLINICAL PAPER PUBLISHED 2017-07-07

Annals of Noninvasive Electrocardiology recently published a paper on KOS effect on the Autonomic Nervous System (ANS). This was a sub-analysis from a Safety Study performed at the Karolinska Trial Alliance. ECGs were evaluated by iCardiac in the US, and findings were that KOS treatment had an effect on Heart Rate Variability (HRV) as a sign of effect on the ANS. Results from the Safety […]

TO HELP PATIENTS WITH RHINITIS IN SAUDI ARABIA 2017-05-22

To help patients with rhinitis, Chordate’s treatment method is launched in Saudi Arabia. A successful launch meeting was organized in Jeddah, Saudi Arabia. The scientific programme was moderated by Prof. Tariq Jamal, King Abdulaziz University, Jeddah. .

LAUNCH OF CHORDATE´S KOS TREATMENT IN SAUDI ARABIA 2017-05-16

Almothihel Medical and Chordate Medical launch KOS treatment for Non-Allergic Rhinitis in Saudi Arabia. A launch meeting will be held on ‘Where are we heading in the treatment of Non Allergic Rhinitis. A new innovation’ organized by the distributor Almothihel Medical and Chordate Medical. May 16, 2017—Almothihel Medical Est. and Chordate Medical AB, announce the launch of the Kinetic Oscillation Stimulation, KOS treatment for Non-Allergic […]

JAPANESE PATENTS GRANTED 2017-04-18

Chordate Medical have been granted Japanese patents covering; a device for detecting rhinitis in a human subject by a pressure sensing system and method, and a system affecting the autonomous nervous system of a person by vibrational stimulation. We continue to strengthen our global IP protection of the technology that forms the base for current and future products. Our IP insurance enable us to protect our patents […]

EU PATENT GRANTED 2017-04-13

Chordate Medical has been granted a EU patent covering a vibrational stimulation system with a vibration pattern at a first and a second frequency. We continue to strengthen our global IP protection of the technology that forms the base for current and future products. Our IP insurance enable us to protect our patents from infringement.

CHINESE PATENT GRANTED 2017-03-21

Chordate Medical has been granted a Chinese patent covering a system for treatment of headache. We continue to strengthen our global IP protection of the technology that forms the base for current and future products. Our IP insurance enable us to protect our patents from infringement.

EU PATENTS GRANTED 2017-03-21

Chordate Medical have been granted two EU patents covering; a device for stimulation of Hypothalamus and a device for double nasal stimulation system for treatment of headache. We continue to strengthen our global IP protection of the technology that forms the base for current and future products. Our IP insurance enable us to protect our patents from infringement.

JAPANESE PATENTS GRANTED 2017-02-13

Chordate Medical have been granted two Japanese patents covering; a device for stimulation of Hypothalamus and a device for treatment of headache disorders. We continue to strengthen our global IP protection of the technology that forms the base for current and future products. Our IP insurance enable us to protect our patents from infringement.

CHORDATE MEDICAL EXHIBITS AT ARAB HEALTH 2017 2017-01-12

Meet us at Arab Health. Chordate will be at Arab Health, Dubai,  30 January – 2 February.  We’re excited to be meeting many customers in the Middle East Area. Look forward to meeting you in in Hall 2, Z2.A50

CHINESE PATENT GRANTED 2016-11-23

Chordate Medical has been granted a Chinese patent covering a device for detecting rhinitis in a human subject by a pressure sensing system and method. We continue to strengthen our global IP protection of the technology that forms the base for current and future products. Our IP insurance enable us to protect our patents from infringement.